Get it on Google Play

Monte Rosa to share Phase 1 MRT-8102 cardiovascular study data

September 30, 2026 4:01 PM EDT Send to a Friend
Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE) announced it will host a conference call and webcast on Oct. 1, 2026, at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login